<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="28226">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01656616</url>
  </required_header>
  <id_info>
    <org_study_id>IRB 4053X</org_study_id>
    <nct_id>NCT01656616</nct_id>
  </id_info>
  <brief_title>Hydroxycobalamin and Rural Emergency Medical Services Cyanide Exposure Patients: A Cost Analysis</brief_title>
  <official_title>Hydroxycobalamin and Rural Emergency Medical Services Cyanide Exposure Patients: A Cost Analysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maine Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maine Medical Center</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The costs to a rural emergency medical services (EMS) system of a change from a traditional
      cyanide antidote kit to a kit containing hydroxocobalamin alone are currently unknown. The
      purpose of this study is to use current EMS data to calculate the costs to a rural EMS
      system associated with the adoption of a hydroxocobalamin protocol for the treatment of
      suspected cyanide exposure.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>August 2012</start_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Retrospective</study_design>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Cyanide Poisoning</condition>
  <arm_group>
    <arm_group_label>EMS cyanide exposure patients</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cyanide antidote administration</intervention_name>
    <arm_group_label>EMS cyanide exposure patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        EMS patients possibly exposed to cyanide via poisoning or smoke exposure.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Included in Maine EMS database

          -  House Fire Victim

          -  Poisoning

        Exclusion Criteria:

          -  No potential cyanide exposure

          -  Incomplete data available
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tania D Strout, PhD, RN, MS</last_name>
    <role>Study Director</role>
    <affiliation>Maine Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tania D Strout, PhD, RN, MS</last_name>
    <phone>207-662-7049</phone>
    <email>strout@mmc.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Maine Medical Center Department of Emergency Medicine</name>
      <address>
        <city>Portland</city>
        <state>Maine</state>
        <zip>04102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Tamas Peredy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tania D Strout, PhD, RN, MS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <lastchanged_date>August 2, 2012</lastchanged_date>
  <firstreceived_date>August 1, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Maine Medical Center</investigator_affiliation>
    <investigator_full_name>Tania D. Strout</investigator_full_name>
    <investigator_title>Director of Research, Department of Emergency Medicine</investigator_title>
  </responsible_party>
  <keyword>Pharmacoeconomics</keyword>
  <keyword>Cost effectiveness</keyword>
  <keyword>Cyanide</keyword>
  <keyword>Fire</keyword>
  <keyword>Emergency Medical Services</keyword>
  <keyword>Smoke Inhalation</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Emergencies</mesh_term>
    <mesh_term>Poisoning</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Antidotes</mesh_term>
    <mesh_term>Hydroxocobalamin</mesh_term>
    <mesh_term>Vitamin B 12</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
